Skip to main content
NCBI home page
Journal of Cancer Research and Clinical Oncology logoLink to Journal of Cancer Research and Clinical Oncology
. 1996 Jul;122(7):416–420. doi: 10.1007/BF01212881

Luteinizing hormone pulsatility and computer-assisted analysis of sperm features in patients with Hodgkin's disease

M Magnanti 1, S Malizia 1, G Garufi 1, A Lenzi 1, F Beligotti 1, A Fabbrini 1, A P Anselmo 2, V Santiemma 1,3,✉
PMCID: PMC12201894  PMID: 8690752

Abstract

The aim of this work was to characterize further the impairment of the reproductive function reported in untreated male patients with Hodgkin's disease. We evaluated the pattern of luteinizing hormone pulsatility and unconventional sperm features by computer-assisted sperm analysis (CASA) in 20 adult patients affected by biopsy-proven Hodgkin's disease before they were submitted to any therapeutic approach. Changes of luteinizing hormone pulsatility were documented and consisted mainly in an increase in pulse number in comparison with control subjects (P<0.05). On CASA, 1/3 of the patients showed a reduction in the sperm number but, when motility, velocity and linearity of progression were evaluated, the number of patients with seminal alterations rose to 2/3. Sperm velocity and linearity were already impaired in stages I and II, whereas sperm number was reduced only in stage III. Symptomatic patients, regardless of the stage, showed a significant deterioration of all parameters. Our study supports the view that in Hodgkin's disease, before any treatment, a disorder of the reproductive system is present, both at hypothalamic/hypophysial and the gonadal level, having a pathogenesis that deserves to be elucidated by further study.

Key words: Hodgkin's disease, Hypothalamic/hypophyseal/gonadal axis, Luteinizing hormone pulsatility, Sperm analysis, Cytokines

Abbreviations

HD

Hodgin's disease

LH

luteinizing hormone

References

  1. Anselmo AP, Cartoni C, Bellantuono P, Maurizi-Enrici R, Aboulkair N, Ermini M (1990) Risk of infertility in patients with Hodgkin's disease treated with ABVD vs MOPP vs MOPP/ABVD. Haematologica 75:155–158 [PubMed] [Google Scholar]
  2. Blackman MR, Wientraub BD, Rosen SW, et al. (1988) Comparison of lung cancer, benign lung disease, and normal aging on pituitary-gonadal function in men. J Clin Endocrinol Metab 66:88 [DOI] [PubMed] [Google Scholar]
  3. Boockfor FR, Schwarz LK (1991) Effects of interleukin-6, interleukin-2 and tumor necrosis factor alpha on transferrin release from Sertoli cells in culture. Endocrinology 129:256–262 [DOI] [PubMed] [Google Scholar]
  4. Chapman RM, Sutcliffe SB, Rees LH, Edwards CRW, Malpas JS (1979) Cyclical combination chemotherapy and gonadal function. Lancet I:285–289 [DOI] [PubMed] [Google Scholar]
  5. Chapman RM, Sutcliffe SB, Malpas JS (1981) Male gonadal dysfunction in Hodgkin's disease. JAMA 245:1323–1328 [PubMed] [Google Scholar]
  6. Chelobowski RT, Herber D (1982) Hypogonadism in male patients with metastatic cancer prior to chemotherapy. Cancer Res 42:2495 [PubMed] [Google Scholar]
  7. Ebisui O, Fukata T, Tominaga T, Murakami N, et al. (1992) Roles of interleukin-1α and 1β in endotoxin-induced suppression of plasma gonadotropin levels in rats. Endocrinology 130:3307–3313 [DOI] [PubMed] [Google Scholar]
  8. Fermé C, Henry-Amar M (1994) Hodgkin's disease management and follow-up revisited. Hematologie 36:209–212 [PubMed] [Google Scholar]
  9. Gause A, Keymis S, Scholz R, Schobert I, Jung W, Diehl V, Pohl C, Pfreundschuh M (1991) Increased levels of circulating cytokines in patients with untreated Hodgkin's disease. Lymphokine Cytokine Res 11:109–113 [PubMed] [Google Scholar]
  10. Greenway B, Ibqal MJ, Johnson M, et al. (1983) Low serum testosterone concentrations in patients with carcinoma of the pancreas. Br Med J 286:93 [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Gruss HJ, Brach MA, Drexler HG, Bonifer R, Mertelsmann RH, Herrmann F (1992) Expression of cytokine genes, cytokine-receptor genes, and transcription factors in cultured Hodgkin and Reed-Sternberg cells. Cancer Res 52:3353–3360 [PubMed] [Google Scholar]
  12. Guo H, Harrington Calkins J, Michael Sigel M, Lin T (1990) Interleukin-2 is potent inhibitor of Leydig cell steroidogenesis. Endocrinology 127:1234–1239 [DOI] [PubMed] [Google Scholar]
  13. Hill JA, Haimovici F, Politich JA, Anderson DJ (1987) Effects of soluble products of activated lymphocytes and macrophages (lymphokines and monokines) on human sperm motion parameters. Fertil Steril 47:460–465 [DOI] [PubMed] [Google Scholar]
  14. Karanth S, McCann S (1991) Anterior pituitary hormone control by interleukin 2. Proc Natl Acad Sci USA 88:2961–2965 [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Kinsella TJ, Trivette G, Rowlamd J, et al. (1989) Long-term follow-up of testicular function following radiation therapy for early-stage Hodgkin's disease. J Clin Oncol 7:718–724 [DOI] [PubMed] [Google Scholar]
  16. Lenzi A, Lombardo F, Gandini L, Fazzi V, Dondero F, Fabbrini A (1991) Computer assisted sperm motility analysis. Acta Eur Fertil 22:109–116 [PubMed] [Google Scholar]
  17. Lyson K, McCann SM (1991) The effect of interleukin-6 on pituitary hormone-release in vivo and in vitro. Neuroendocrinology 54:262–266 [DOI] [PubMed] [Google Scholar]
  18. Poll T van der, Romijn JA, Endert E, Sauerwein HP (1993) Effects of tumor necrosis factor on the hypothalamic-pituitary-testicular axis in healthy men. Metabolism 42:303–307 [DOI] [PubMed] [Google Scholar]
  19. Ragni G, Bestetti O, Santoro A, Viviani S, Di Pietro R, De Lauretis L (1985) Evaluation of semen pituitary gonadotropin function in men with untreated Hodgkin's disease. Fertil Steril 43:927–930 [DOI] [PubMed] [Google Scholar]
  20. Spangelo BL, Judd AM, Isakson PC, MacLeod RM (1989) Interleukin-6 stimulates anterior pituitary hormone release in vitro. Endocrinology 125:575–577 [DOI] [PubMed] [Google Scholar]
  21. Syed V, Gerard N, Kaipia A, Wayne Bardin C, Parvinen M, Jegou B (1993) Identification, ontogeny, and regulation of an interleukin-6-like factor in the rat seminiferous tubule. Endocrinology 132:293–299 [DOI] [PubMed] [Google Scholar]
  22. Tesch H, Feller AC, Jucker M, Klein S, Merz H, Diehl V (1992) Activation of cytokines in Hodgkin's disease. Ann Oncol 3 [Suppl 4]:S13-S16 [DOI] [PubMed] [Google Scholar]
  23. Urba WJ, Longo DL (1992) Hodgkin's disease. N Engl J Med 326:678–687 [DOI] [PubMed] [Google Scholar]
  24. Valagussa P, Santoro A, Bonadonna G (1992) Thyroid, pulmonary, and cardiac sequelae after treatment for Hodgkin's disease. Ann Oncol 3 [Suppl 4]:111–115 [DOI] [PubMed] [Google Scholar]
  25. Veldhuis JD, Johonson ML (1986) Cluster analysis: a simple, versatile, and robust algorithm for endocrine pulse detection. Am J Physiol 250:E486-E493 [DOI] [PubMed] [Google Scholar]
  26. Veldhuis JD, Urban RJ, Dufau ML (1992) Evidence that androgen negative feed-back regulates hypotalamic gonadotropin releasing hormone impulse strength and burst-like secretion of biologically active luteinizing hormone in men. J Clin Endocrinol Metab 74:1227–35 [DOI] [PubMed] [Google Scholar]
  27. Vigersky RA, Chapman RM, Berenberg J, Glass AR (1982) Testicular dysfunction in untreated Hodgkin's disease. Am J Med 73:482–486 [DOI] [PubMed] [Google Scholar]
  28. Viviani S, Santoro A, Ragni G, Bonfante V, Bestetti O, Bonadonna G (1985) Gonadal toxicity after combination chemotherapy for Hodgkin's disease. Comparative results of MOPP vs ABVD. Eur J Cancer Clin Oncol 21:601–605 [DOI] [PubMed] [Google Scholar]

Articles from Journal of Cancer Research and Clinical Oncology are provided here courtesy of Springer

RESOURCES